<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000350223">
  <TermName>amonafide</TermName>
  <TermPronunciation>(ay-MOH-nah-fide)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called topoisomerase inhibitors and intercalating agents.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000730758" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;amonafide&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000730759" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;amonafida&quot;" language="es" id="_4"/>
  <SpanishTermName>amonafida</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Es un tipo de inhibidor de la topoisomerasa y un intercalante.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2003-12-23</DateFirstPublished>
</GlossaryTerm>
